Factor Xa inhibitors in clinical practice: Comparison of pharmacokinetic profiles
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology
Reference37 articles.
1. Pharmacodynamic and pharmacokinetic basics of rivaroxaban;Kreutz;Fundam Clin Pharmacol,2012
2. Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor;He;Eur J Drug Metab Pharmacokinet,2011
3. Edoxaban population pharmacokinetics and exposure-response analysis in patients with non-valvular atrial fibrillation;Yin;Eur J Clin Pharmacol,2014
4. Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation;Salazar;Thromb Haemost,2012
5. Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor;Wong;J Thromb Thrombolysis,2011
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Population pharmacokinetics of rivaroxaban in Chinese deep vein thrombosis patients and the exposure simulation for dosing recommendation;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-11
2. Effect of PCC on Thrombin Generation among Patients on Factor Xa Inhibitors with Major Bleeding or Needing Urgent Surgery (GAUGE): Design and Rationale;TH Open;2023-07
3. Prospective randomized trial of antithrombotic strategies following great saphenous vein ablation using injectable polidocanol endovenous microfoam (Varithena);Journal of Vascular Surgery: Venous and Lymphatic Disorders;2023-05
4. Transferability of Published Population Pharmacokinetic Models for Apixaban and Rivaroxaban to Subjects with Obesity Treated for Venous Thromboembolism: A Systematic Review and External Evaluations;Pharmaceutics;2023-02-16
5. Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban;Pharmaceutics;2023-02-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3